Patents Assigned to Genencor International, Inc.
  • Publication number: 20120270298
    Abstract: Described herein are variants of H. jecorina CBH I, a Cel7 enzyme. The present invention provides novel cellobiohydrolases that have improved thermostability and reversibility.
    Type: Application
    Filed: June 14, 2012
    Publication date: October 25, 2012
    Applicants: GENENCOR INTERNATIONAL, INC., DANISCO US INC.
    Inventors: Anthony Day, Frits Goedegebuur, Peter Gualfetti, Colin Mitchinson, Paulien Neefe, Mats Sandgren, Andrew Shaw, Jerry Stahlberg
  • Patent number: 8192959
    Abstract: This invention provides a series of low-copy number plasmids comprising restriction endonuclease recognition sites useful for cloning at least three different genes or operons, each flanked by a terminator sequence, the plasmids containing variants of glucose isomerase promoters for varying levels of protein expression. The materials and methods are useful for genetic engineering in microorganisms, especially where multiple genetic insertions are sought.
    Type: Grant
    Filed: April 22, 2003
    Date of Patent: June 5, 2012
    Assignees: Genencor International Inc, E I du Pont de Nemours and Company
    Inventors: Mark S. Payne, Stephen K. Picataggio, Amy K. Hsu, Ramesh V. Nair, Fernando Valle, Philippe Soucaille, Donald E. Trimbur
  • Publication number: 20110229956
    Abstract: Described herein are variants of H. jecorina CBH I, a Cel7 enzyme. The present invention provides novel cellobiohydrolases that have improved thermostability and reversibility.
    Type: Application
    Filed: May 13, 2011
    Publication date: September 22, 2011
    Applicants: Danisco US Inc., Genencor International, Inc.
    Inventors: Anthony Day, Frits Goedegebuur, Peter Gualfetti, Colin Mitchinson, Paulien Neefe, Mats Sandgren, Andrew Shaw, Jerry Stahlberg
  • Publication number: 20110223639
    Abstract: The present invention concerns a method of producing glucose from a granular starch substrate comprising, contacting a slurry comprising granular starch obtained from plant material with an alpha-amylase at a temperature below the starch gelatinization temperature of the granular starch to produce oligosaccharides and hydrolyzing the oligosaccharides to produce a mash comprising at least 20% glucose and further comprising fermenting the mash to obtain ethanol.
    Type: Application
    Filed: May 23, 2011
    Publication date: September 15, 2011
    Applicant: Genencor International, Inc.
    Inventors: Oreste J. LANTERO, Mian Li, Jayarama K. Shetty
  • Publication number: 20110160440
    Abstract: The present invention relates to CAB molecules, ADEPT constructs directed against CEA, and their use in diagnosis and therapy.
    Type: Application
    Filed: December 10, 2004
    Publication date: June 30, 2011
    Applicant: GENENCOR INTERNATIONAL, INC.
    Inventors: Judith A. Fox, Fiona A. Harding, Volker Schellenberger
  • Patent number: 7968318
    Abstract: A method is disclosed for producing glucose from a granular starch substrate including, contacting a slurry comprising granular starch obtained from plant material with an alpha-amylase at a temperature below the starch gelatinization temperature of the granular starch to produce oligosaccharides and hydrolyzing the oligosaccharides to produce a mash comprising at least 20% glucose and further comprising fermenting the mash to obtain ethanol.
    Type: Grant
    Filed: June 6, 2006
    Date of Patent: June 28, 2011
    Assignee: Genencor International, Inc.
    Inventors: Oreste J. Lantero, Mian Li, Jayarama K. Shetty
  • Patent number: 7858762
    Abstract: An evolvable production strain of B. subtilis exhibiting continuous or high level expression during protein evolution is described. An evolved Bacillus subtilis pstS promoter facilitates screening and production of secreted proteins.
    Type: Grant
    Filed: July 26, 2002
    Date of Patent: December 28, 2010
    Assignee: Genencor International, Inc.
    Inventors: Katherine D Collier, Edwin Lee, Nicholas Leiva, Thomas B Morrison, Volker Schellenberger, Olga V Selifonova, Adam C Kean
  • Publication number: 20100261232
    Abstract: Novel variant ?-amylase enzymes are disclosed in which the residues corresponding to R179 and G180 in Bacillus stearothermophilus (SEQ ID NO.2) are deleted. The disclosed variant ?-amylase enzymes show altered or improved stability and/or activity profiles.
    Type: Application
    Filed: March 9, 2009
    Publication date: October 14, 2010
    Applicant: GENENCOR INTERNATIONAL, INC.
    Inventors: Eugenio Ferrari, Marc Kolkman, Craig E. Pilgrim
  • Patent number: 7803591
    Abstract: Described are multimeric oxidoreductase complexes which function in the enzymatic conversion of a carbon substrate. The complexes having a dehydrogenase subunit and a cytochrome C subunit. Also described are polynucleotides coding for the multimeric complexes and methods of use thereof.
    Type: Grant
    Filed: October 16, 2007
    Date of Patent: September 28, 2010
    Assignee: Genencor International, Inc.
    Inventors: Robert M. Caldwell, M. Harunur Rashid, Fernando Valle
  • Publication number: 20100221775
    Abstract: Described herein are methods for increasing the amount of protein secreted by a cell. In one case, a cell is provided which contains a heterologous nucleic acid encoding a protein having unfolded protein response modulating activity and a heterologous nucleic acid encoding a protein of interest to be secreted. In one case, the protein having unfolded protein response modulating activity is selected from the proteins selected from the group consisting of HAC1, PTC2 and IRE1. The protein of interest can be any secreted protein such as a therapeutic or an industrial enzyme. For example the protein can be selected from the group consisting of lipase, cellulase, endo-glucosidase H, protease, carbohydrase, reductase, oxidase, isomerase, transferase, kinase, phosphatase, alpha-amylase, glucoamylase, lignocellulose hemicellulase, pectinase and ligninase.
    Type: Application
    Filed: December 16, 2009
    Publication date: September 2, 2010
    Applicant: Genencor International, Inc.
    Inventors: Merja E. Penttila, Michael Ward, Huaming Wang, Mari J. Valkonen, Markku L.A. Saloheimo
  • Patent number: 7745189
    Abstract: The present invention generally relates to hyphal growth in fungi and in particular describes the modulation of genes associated with hyphal growth in filamentous fungi. The present invention provides methods and systems for the production of proteins and/or chemicals from filamentous fungi which comprise modulation of genes associated with hyphal growth. Specifically, the present invention is directed to a full length cotA gene, its gene product and methods of use.
    Type: Grant
    Filed: July 31, 2008
    Date of Patent: June 29, 2010
    Assignee: Genencor International, Inc.
    Inventors: Ali R. Akin, Elizabeth A. Bodie, Shirley M. Burrow, Nigel Dunn-Coleman, Geoffrey Turner, Michael Ward
  • Patent number: 7745184
    Abstract: The present invention provides a microorganism useful for biologically producing 1,3-propanediol from a fermentable carbon source at higher yield than was previously known. The complexity of the cofactor requirements necessitates the use of a whole cell catalyst for an industrial process that utilizes this reaction sequence to produce 1,3-propanediol. The invention provides a microorganism with disruptions in specified genes and alterations in the expression levels of specified genes that is useful in a higher yielding process to produce 1,3-propanediol.
    Type: Grant
    Filed: March 24, 2008
    Date of Patent: June 29, 2010
    Assignees: E. I. du Pont de Nemours and Co., Genencor International Inc.
    Inventors: Marguerite A. Cervin, Philippe Soucaille, Fernando Valle
  • Patent number: 7723079
    Abstract: The present invention is related to glucoamylases having at least 80% sequence identity to a Trichoderma glucoamylase having the sequence of SEQ ID NO: 4 and biologically functional fragments thereof. The invention is also related to DNA sequences coding for the glucoamylases, vectors and host cells incorporating the DNA sequences, enzyme compositions and methods of using the glucoamylases in various applications.
    Type: Grant
    Filed: July 21, 2008
    Date of Patent: May 25, 2010
    Assignee: Genencor International, Inc.
    Inventors: Nigel Dunn-Coleman, Paulien Neefe-Kruithof, Craig E. Pilgrim, Piet Van Solingen, Donald E. Ward, III
  • Publication number: 20100124586
    Abstract: A stable, durable granule for feed compositions has a core, at least one active agent; and at least one coating. The active agent of the granule retains at least 50% activity, at least 60% activity, at least 70% activity, at least 80% activity after conditions selected from one or more of a) a feed pelleting process, b) a steam-heated feed pretreatment process, c) storage, d) storage as an ingredient in an unpelleted mixture, and e) storage as an ingredient in a feed base mix or a feed premix comprising at least one compound selected from trace minerals, organic acids, reducing sugars, vitamins, choline chloride, and compounds which result in an acidic or a basic feed base mix or feed premix.
    Type: Application
    Filed: October 12, 2006
    Publication date: May 20, 2010
    Applicant: GENENCOR INTERNATIONAL, INC.
    Inventors: Nathaniel T. Becker, Kathleen A. Clarkson, Douglas A. Dale, Beth Fryksdale, Mark S. Gebert, Michael Partsuf, Troels N. Gravesen
  • Publication number: 20100120651
    Abstract: Single-dose enzyme tablets for direct sale to consumers are provided for boosting the performance of automatic laundry and dish washing operations using conventional detergents. The tablets provide a wash performance that is better than or at least equal to the wash performance of the detergents alone even when the time and or temperature of the wash cycle is decreased. The tablets may be provided in kits and the enzymes are selected to treat a variety of fabric stains as well as to provide fabric care benefits.
    Type: Application
    Filed: July 11, 2006
    Publication date: May 13, 2010
    Applicant: GENENCOR INTERNATIONAL, INC.
    Inventors: Douglas A. Dale, David A. Estell, Beth Fryksdale, Alfred L. Gaertner, Kenneth F. Herfert, Philippe Lavielle, Janet C. Naab, Thomas Pekich
  • Patent number: 7691806
    Abstract: Biomolecular conjugates are provided which comprise the conjugation product of a repeat sequence protein polymer and at least one active agent. Additional aspects provide methods for their manufacture and various industrial and consumer applications.
    Type: Grant
    Filed: February 10, 2006
    Date of Patent: April 6, 2010
    Assignee: Genencor International, Inc.
    Inventors: Katherine D. Collier, William A. Cuevas, Manoj Kumar
  • Publication number: 20100040728
    Abstract: The invention pertains to an in situ process for producing fructooligosaccharides in a food product by contacting the food product with a fructosyltransferase to enzymatically convert sucrose to fructooligosaccharides in the food product. The increase in fructooligosaccharides results in an increase in dietary fiber content of the food product.
    Type: Application
    Filed: November 17, 2006
    Publication date: February 18, 2010
    Applicant: GENENCOR INTERNATIONAL, INC.
    Inventors: Wayne E. Henderson, William King, Jayarama K. Shetty
  • Patent number: 7642077
    Abstract: This invention relates to a method of immobilizing biocatalysts including protein and cells by co-precipitation with silicate or organosilicate matrices through the action of an organic template molecule. The organic template molecule is in general a polyamine such as polyethylenimine (PEI), or polypeptide compound bearing at least two or three basic residues selected from the group consisting of lysine, arginine, histidine, proline, hydroxyproline, N-methylhistidine, ornithine, taurine, ?-hydroxylysine, and ?-hydroxy-?-N,N,N trimethyllysine. The invention is also directed to a silica biocomposite comprising co-precipitates of active biocatalysts, silica or organosilicates, and an N-containing organic template molecule. Such silica biocomposites are useful in biocatalysis, and other applications requiring an immobilized biocatalyst. Preferred biocatalysts for this invention are enzymes and whole cells.
    Type: Grant
    Filed: December 7, 2004
    Date of Patent: January 5, 2010
    Assignee: Genencor International, Inc.
    Inventors: Risha Bond, Michael C. Jewett, Joseph C. McAuliffe, Donald E. Ward, II
  • Patent number: 7638613
    Abstract: The invention relates to a xylanase originating from a Bacillus strain. This xylanase is active over a wide range of acid and basic pH. The invention also relates to new strains of microorganisms producing this xylanase and to methods for preparing this xylanase. The invention also relates to a DNA molecule and to an expression vector or an integration vector containing this DNA molecule. The invention also relates to uses of the latter and to compositions containing it.
    Type: Grant
    Filed: July 8, 2005
    Date of Patent: December 29, 2009
    Assignee: Genencor International, Inc.
    Inventors: Eric De Buyl, Andrée Lahaye, Pierre Ledoux, René Detroz
  • Patent number: 7638073
    Abstract: The present invention relates to a photochromic material comprising a proteorhodopsin apoprotein and a retinal analog. In one embodiment, the retinal analog is an azulenic retinoid compound. In another embodiment, the retinal analog is a compound that is structurally similarly to all-trans-retinal. The proteorhodopsin apoprotein and the retinal analog form a photochromic material having different spectral properties from those of a corresponding photochromic material formed by the same proteorhodopsin apoprotein and all-trans-retinal. In one embodiment of the application, the retinal analog-containing proteorhodopsin has an absorbance spectrum that does not overlap significantly with that of all-trans-retinal-containing proteorhodopsin. In another embodiment of the application, the retinal analog-containing proteorhodopsin yields a red-shifted visual chromophore compared with the all-trans-retinal-containing proteorhodopsin chromophore.
    Type: Grant
    Filed: June 9, 2005
    Date of Patent: December 29, 2009
    Assignee: Genencor International, Inc.
    Inventors: Rasmus B. Jensen, Bradley R. Kelemen, Donald E. Ward, II, Alfred E. Asato